As shown in Figure 1C, we found that BRAF expression was correlated with pathological stages in several tumor types, including COAD, KIRC, LUSC, and ovarian serous cystadenocarcinoma (OV) (p < 0.05). This evidence concerns the gene BRAF and ovarian serous cystadenocarcinoma.